Teva Pharmaceutical Industries
TEVA
#672
Rank
NZ$64.68 B
Marketcap
NZ$54.22
Share price
-1.17%
Change (1 day)
144.42%
Change (1 year)

EPS for Teva Pharmaceutical Industries (TEVA)

EPS in 2025 (TTM): NZ$2.13

According to Teva Pharmaceutical Industries's latest financial reports the company's current EPS (TTM) is NZ$2.10. In 2024 the company made an earnings per share (EPS) of NZ-$2.46 a decrease over its 2023 EPS that were of NZ-$0.80.

EPS history for Teva Pharmaceutical Industries from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.13-186.6%
2024NZ-$2.46208.51%
2023NZ-$0.80-77.83%
2022NZ-$3.59-657.89%
2021NZ$0.64
2019NZ-$1.56-60.34%
2018NZ-$3.93-85.73%
2017NZ-$27.53-23328.57%
2016NZ$0.12-96.2%
2015NZ$3.12-48.6%
2014NZ$6.06138.67%
2013NZ$2.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.19 480.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.30 9.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.50 66.55%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$12.38 489.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.04 378.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.38 203.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
NZ$1.32-37.21%๐Ÿ‡ฎ๐Ÿ‡ณ India